Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Option Care Health (OPCH)

Option Care Health Q2 revenue rises 15.4% to $1.42 billion; adjusted EPS $0.41

Positive Impact 3 of 5 earnings Written later

Option Care Health reported second quarter 2025 results on July 30, 2025, with net revenue of $1.42 billion, up 15.4% from a year earlier, and adjusted diluted EPS of $0.41, up 10.8%. GAAP net income slipped to $50.5 million from $53.0 million, while operating cash flow fell to $90.3 million from $195.7 million, and the company updated its full-year 2025 guidance.

Key points

  • Q2 net revenue $1,416.1 million, up 15.4% from $1,227.2 million; gross margin 19.0% versus 20.3% a year earlier
  • Diluted EPS $0.31 versus $0.30; net income $50.5 million versus $53.0 million; adjusted diluted EPS $0.41 versus $0.37
  • Operating cash flow $90.3 million versus $195.7 million in Q2 2024; about $50.0 million of stock repurchased in the quarter
  • Updated 2025 guidance: net revenue $5.50 billion to $5.65 billion, adjusted diluted EPS $1.65 to $1.72, adjusted EBITDA $465 million to $475 million

The filing

CompanyOption Care Health (OPCH)
Form8-K, current report
Filed with the SECJul 30, 2025, 6:58 AM ET
Accession number0001014739-25-000034

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:00 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.